• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Q-MED AB SOLESTA; AGEN, BULKING, INJECTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Q-MED AB SOLESTA; AGEN, BULKING, INJECTABLE Back to Search Results
Device Problem No Apparent Adverse Event (3189)
Patient Problems Abscess (1690); Abdominal Distention (2601)
Event Date 11/22/2013
Event Type  Injury  
Event Description
A (b)(6) yr old female rec'd solesta (dextranomer/hyaluronic acid) injection into the submucosa of the anal canal as treatment for fecal incontinence.Add'l medical history included aortic regurgitation, fibromyalgia, and interstim ((b)(6) 2013).Concurrent medications were duloxetine, gabapentin, and multivitamins.On (b)(6) 2013, the pt rec'd solesta.She immediately experienced abdominal bloating and a rectal abscess on (b)(6) 2013, the pt underwent surgery to repair the rectal abscess.The pt has continued to experience severe pain from the rectal abscess.On a pain scale of 1-10, her pain was reported as an 8 or 9.She has been taking oxycodone with no improvement.The outcome was unchanged at the time of this report.The company felt the events were possibly related to solesta.
 
Manufacturer Narrative
A causal relation between the events and the treatment seems possible.The injection technique or the injection per se may also have contributed to the event.The reported events are addressed in the label.Lot number was not reported and trending on batch cannot be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLESTA
Type of Device
AGEN, BULKING, INJECTABLE
Manufacturer (Section D)
Q-MED AB
uppsala
SW 
Manufacturer (Section G)
Q-MED AB
seminariegatan 21
uppsala SE-7 52 2
SW   SE-752 28
Manufacturer Contact
8510 colonnade center drive
raleigh, NC 27615
9198621000
MDR Report Key3590755
MDR Text Key4186080
Report Number3009325614-2014-00001
Device Sequence Number1
Product Code LNM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 01/15/2014,12/23/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/15/2014
Distributor Facility Aware Date12/23/2013
Date Report to Manufacturer01/03/2014
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/15/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GABAPENTIN; MULTIVITAMINS; CYMBALTA
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient Weight54
-
-